We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

179 hedge funds and large institutions have $826M invested in Acorda Therapeutics in 2018 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 64 increasing their positions, 55 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

154% more call options, than puts

Call options by funds: $38.5M | Put options by funds: $15.2M

37% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 19

16% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 55

3% more funds holding

Funds holding: 174 → 179 (+5)

19% less capital invested

Capital invested by funds: $1.01B → $826M (-$189M)

Holders
179
Holders Change
+5
Holders Change %
+2.87%
% of All Funds
3.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
64
Reduced
55
Closed
19
Calls
$38.5M
Puts
$15.2M
Net Calls
+$23.3M
Net Calls Change
-$2.58M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$16.5M
2
BlackRock
BlackRock
New York
+$15.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$13M
4
Marshall Wace
Marshall Wace
United Kingdom
+$7.23M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$5.58M

Top Sellers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
-$29.3M
2
Bank of America
Bank of America
North Carolina
-$7.81M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$5.62M
4
Deutsche Bank
Deutsche Bank
Germany
-$4.82M
5
First Trust Advisors
First Trust Advisors
Illinois
-$3.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
QI
51
QS Investors
New York
$1.59M – – –
Legal & General Group
52
Legal & General Group
United Kingdom
$1.47M +$8.7K +4 +0.5%
PAM
53
Panagora Asset Management
Massachusetts
$1.46M -$13.1K -6 -0.8%
Massachusetts Financial Services
54
Massachusetts Financial Services
Massachusetts
$1.45M +$131K +60 +8%
SEI Investments
55
SEI Investments
Pennsylvania
$1.4M – – –
JG
56
Jefferies Group
New York
$1.4M -$163K -75 -9%
State of New Jersey Common Pension Fund D
57
State of New Jersey Common Pension Fund D
New Jersey
$1.4M – – –
CAM
58
ClariVest Asset Management
California
$1.34M +$603K +277 +63%
BPM
59
Bowling Portfolio Management
Ohio
$1.32M +$1.29M +591 +523%
California Public Employees Retirement System
60
California Public Employees Retirement System
California
$1.3M -$113K -52 -7%
CS
61
Credit Suisse
Switzerland
$1.23M +$26.1K +12 +2%
Wells Fargo
62
Wells Fargo
California
$1.21M +$115K +53 +9%
OTPPB
63
Ontario Teachers' Pension Plan Board
Ontario, Canada
$1.21M +$1.41M +647 New
Morgan Stanley
64
Morgan Stanley
New York
$1.12M -$942K -433 -42%
AllianceBernstein
65
AllianceBernstein
Tennessee
$1.12M -$91.4K -42 -7%
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$1.11M +$302K +139 +31%
Tudor Investment Corp
67
Tudor Investment Corp
Connecticut
$1.08M +$1.26M +578 New
California State Teachers Retirement System (CalSTRS)
68
California State Teachers Retirement System (CalSTRS)
California
$1.06M +$28.3K +13 +2%
Swiss National Bank
69
Swiss National Bank
Switzerland
$1.05M +$37K +17 +3%
SFM
70
Systematic Financial Management
New Jersey
$1.04M +$385K +177 +46%
GCP
71
GSA Capital Partners
United Kingdom
$949K – – –
ASRS
72
Arizona State Retirement System
Arizona
$947K +$67.5K +31 +7%
New York State Teachers Retirement System (NYSTRS)
73
New York State Teachers Retirement System (NYSTRS)
New York
$923K -$4.35K -2 -0.4%
AIM
74
Assured Investment Management
New York
$858K +$746K +343 +296%
WAM
75
Wolverine Asset Management
Illinois
$853K +$994K +457 New
1 2
3
4 5

ACOR Hedge Fund Activity: Q4 2018 in Review

179 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q4 2018, worth a combined $826M — down 19% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ACOR positions and 19 closed out — a net gain of 7 holders — while 64 added to existing stakes and 55 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $16.5M. The largest seller was Scopia Capital Management, cutting an estimated $29.3M.

  • 179 institutional investors held Acorda Therapeutics (ACOR) as of Q4 2018, up from 174 in Q3 2018.
  • Funds reported $826M of Acorda Therapeutics stock for Q4 2018, down 19% quarter-over-quarter.
  • 26 funds opened new Acorda Therapeutics positions in Q4 2018 and 19 closed out, a net change of +7 holders.
  • The largest Acorda Therapeutics buyer in Q4 2018 was Renaissance Technologies, an estimated $16.5M added.
  • The largest Acorda Therapeutics seller in Q4 2018 was Scopia Capital Management, an estimated $29.3M sold.

Based on aggregated 13F filings for Q4 2018.